The immunotherapy paradox in high-risk non-muscle-invasive bladder cancer: A tale of three trials
Indian Journal of Urology · 2026-07 · 42 (3) · 254-255
DOI: 10.4103/iju.iju_98_26 ↗Kurz gefasst
Leserbrief in der Zeitschrift Indian Journal of Urology, online erschienen am 30.06.2026. Verfasst von Shashank Agrawal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department Urology, Sindhu Hospital, Hyderabad, Telangana, India. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department Urology, Sindhu Hospital, Hyderabad, Telangana, India.
- Department Urology, Aster Medicity, Kochi, Kerala, India.
- Department Urology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
- Department Urology, CRAAFt and Jyoti Hospital, New Delhi, India.
- Department Urology, Manipal Hospital, Delhi, India.
Zitieren
APA
Agrawal, S., Pal, A. K., Sharma, S., Tanwar, R., & Sharma, G. (2026). The immunotherapy paradox in high-risk non-muscle-invasive bladder cancer: A tale of three trials. Indian Journal of Urology, 42(3), 254-255. https://doi.org/10.4103/iju.iju_98_26
Vancouver
Agrawal S, Pal AK, Sharma S, Tanwar R, Sharma G. The immunotherapy paradox in high-risk non-muscle-invasive bladder cancer: A tale of three trials. Indian Journal of Urology. 2026;42(3):254-255. doi:10.4103/iju.iju_98_26
BibTeX
@article{Agrawal2026,
author = {Agrawal, Shashank and Pal, Atanu Kumar and Sharma, Satyadeo and Tanwar, Raman and Sharma, Gopal},
title = {The immunotherapy paradox in high-risk non-muscle-invasive bladder cancer: A tale of three trials},
journal = {Indian Journal of Urology},
year = {2026},
volume = {42},
number = {3},
pages = {254--255},
doi = {10.4103/iju.iju_98_26}
}
EUVIMED